TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive In Brief: Katterhagen Committee to Meet On PDQ Questions; ACS Grants Total Highest In History, $57 Million August 19, 1983
TCL Archive ACS Plans To Award 10 New Institutional Grants For Up to $200,000 A Year In Cause And Prevention November 16, 1979
TCL Archive Chabner Says Some Group Satellites Causing Concern Because Of Lack Communications March 4, 1983
